Star Source Multi Trade
110.50
-110.50(-100.00%)
Market Cap₹16.60 Cr
PE Ratio-1.36
IndustryHealthcare
Company Performance:
1D-100.00%
1M-100.00%
6M-100.00%
1Y-100.00%
5Y-100.00%
View Company Insightsright
More news about Star Source Multi Trade
24Jul 25
Chemo Pharma Laboratories' Statutory Auditors Resign Ahead of Term Completion
Sanjay Rane & Associates LLP, statutory auditors of Chemo Pharma Laboratories Limited, resigned effective July 23, 2025, citing pre-occupation with other assignments. This resignation comes nearly two years before their scheduled term completion. The auditors recently signed the FY 2024-25 audit report and assured no disputes with management or concerns about information suppression. Chemo Pharma has informed the Bombay Stock Exchange as per SEBI regulations but has not yet announced a replacement.
21Jul 25
Chemo Pharma Promoter Atibha Agriseeds Boosts Stake to 27.88% with Share Purchase
Atibha Agriseeds Private Limited, a promoter of Chemo Pharma Laboratories Ltd, has increased its stake in the company from 24.63% to 27.88%. The promoter acquired 48,781 equity shares (3.25% stake) through market purchases on the BSE for Rs 48.78 lakh on July 18, 2025. The transaction was disclosed to SEBI as per regulatory requirements. Ruchit Mehta holds positions in both companies, serving as Managing Director at Chemo Pharma and Director at Atibha Agriseeds.
Star Source Multi Trade
110.50
-110.50
(-100.00%)
1 Year Returns:-100.00%
Industry Peers
Sun Pharmaceutical
1,782.00
(+0.26%)
Divis Laboratories
6,390.50
(-1.11%)
Torrent Pharmaceuticals
3,687.30
(-0.92%)
Cipla
1,517.90
(-0.74%)
Dr Reddys Laboratories
1,247.40
(-0.10%)
Zydus Life Science
926.35
(-0.18%)
Lupin
2,032.60
(+0.09%)
Mankind Pharma
2,242.00
(+0.11%)
Aurobindo Pharma
1,210.70
(+0.25%)
Alkem Laboratories
5,694.00
(-0.11%)